About US
Contact us
-
Researchers from BASF and KIT jointly develop integrated processes to produce nanostructured functional materialsThe Karlsruhe Institute of Technology (KIT) and BASF SE have founded “IP3” (innovative products, intelligent particles, integrated processes), a joint laboratory for process technology in Karlsruhe. J2009/12/21
-
Application Form for Importing New Strain2009/12/18
-
Evonik:One Hundred Fifty Million Euros Invested in Solar Energy and Electronics Markets of the Futureovember 24, 2009 Construction of an integrated production plant for monosilane and AEROSIL® in Japan Entry into thin-layer photovoltaics First step with monosilanes taken in the highly attr2009/12/18
-
Clavis Pharma Reports Positive Phase II Clinical Data for ElacytarabineClavis Pharma ASA recently announced that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AM2009/12/18
-
SFDA:Application and approval procedure for clinical trialsSource: Web of SFDA2009/12/17
-
BASF increases prices in Europe for Dimethylaminopropylamine and DimethylacetamideWith immediate effect , BASF is increasing the sales prices for the Methylamines derivatives Dimethylaminopropylamine (DMAPA) and Dimethylacetamide (DMAc) in Europe as follows: Dimethylaminopropyla2009/12/17
-
Tris Pharma Announces NDA Approvals From FDA, Including First-Ever 24-Hour Liquid Sustained-Release ProductTris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, recently announced that the US FDA has approved its first two NDAs based on its proprietary OralXR+2009/12/17
-
Azopharma Refocuses on Core Capabilities & Restructures ManagementAzopharma Product Development Group has integrated its services to offer a more streamlined approach to product development. Focus has returned to Azopharma’s core capabilities, including prec2009/12/16
-
2010 Annual IPEC Europe Seminar – January 28, 20102010 Annual IPEC Europe Seminar – January 28, 2010, Gray d’Albion Hotel Cannes, France Provisional Program “Taking Excipients into the Next Decade” Keynote Address: Pharmacopoeias in the 21s2009/12/16
-
DAVISCO Foods & MEGGLE Announce Joint VentureAnnounced this past by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, an2009/12/16